Aura Biosciences, Inc.
AURA
$6.55
$0.081.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -101.38M | -94.70M | -86.92M | -83.22M | -80.69M |
| Total Depreciation and Amortization | 1.18M | 1.21M | 1.22M | 1.26M | 1.29M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.96M | 10.20M | 8.53M | 8.39M | 8.27M |
| Change in Net Operating Assets | 4.89M | 4.58M | -2.64M | 334.00K | -2.24M |
| Cash from Operations | -83.35M | -78.71M | -79.81M | -73.24M | -73.37M |
| Capital Expenditure | -866.00K | -1.35M | -1.25M | -1.27M | -1.02M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 90.24M | 90.59M | 70.07M | -49.72M | -38.23M |
| Cash from Investing | 89.37M | 89.24M | 68.82M | -50.99M | -39.25M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 47.87M | 1.44M | 1.60M | 94.04M | 94.95M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 23.41M | -- | -- | -- | -- |
| Cash from Financing | 71.28M | 1.44M | 1.60M | 94.04M | 94.95M |
| Foreign Exchange rate Adjustments | -12.00K | -21.00K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.29M | 11.95M | -9.39M | -30.20M | -17.68M |